Search clinical trials for: Placebo lipid suspension

Total 59039 results

Harvard School of Public Health (HSPH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Trial of Zinc and Micronutrients in Tanzanian Children

Respiratory Illness | Growth Faltering | Diarrheal Illnesses

Tanzania
Sandoz

Completed

Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions

Infections
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
University of Alabama at Birmingham
University of Michigan; Tulane University; Temple University

Recruiting

GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (GKT137831)

Idiopathic Pulmonary Fibrosis

United States
Kitozyme
Naturalpha

Completed

Efficacy and Safety of a Fungal Chitosan on the Body Weight Reduction in Overweight and Obesity Volunteers

Overweight and Obese Volunteers.

France
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)

Hypercholesterolemia

United States
University of Pittsburgh
The Craig H. Neilsen Foundation

Completed

Effects of In-Wheel Suspension

Fatigue | Back Pain | Neck Pain | Spinal Cord Injuries

United States
NYU Langone Health

Completed

The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants

Dysphagia

United States
GE Healthcare

Completed

A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. (OSSAR)

Echocardiography

United States
Shanghai University of Traditional Chinese Medicine
Ministry of Science and Technology of the People´s Republic of China

Completed

Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

Pulmonary Tuberculosis

China
Dafra Pharma
Kenya Medical Research Institute

Completed

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Malaria, Falciparum

Kenya
Fluart Innovative Vaccine Ltd, Hungary

Completed

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Human Influenza

Hungary
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Active, not recruiting

Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD

Limbal Stem Cell Deficiency

United States, Germany
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations

Healthy

Belgium
Galapagos NV

Completed

Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food

Healthy

Belgium
Alcon Research

Completed

Anecortave Acetate in Patients With Open-angle Glaucoma

Open-angle Glaucoma
Alcon Research

Completed

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

Eye Diseases

Spain, United States, Hungary, Brazil, Italy, Netherlands, Puerto Rico, United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Completed

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Gastro-esophageal Reflux Disease (GERD)

China
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

Hypercholesterolemia

Japan
Sun Yat-sen University

Recruiting

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial (KDR-NVG)

Neovascular Glaucoma | Neovascularization

China
Kowa Company, Ltd.

Completed

K-924 Phase III Confirmatory Study

Hypercholesterolemia

Japan
Hanmi Pharmaceutical Company Limited

Unknown

Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

Hyperlipidemias

Korea, Republic of
Sandoz

Completed

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions

Healthy
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Healthy

Canada
Assiut University

Unknown

Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction

Androgenetic Alopecia

Egypt
Statens Serum Institut

Completed

Treatment Study of Metronidazole to Treat Dientamoebiasis in Children (DFPT)

Dientamoebiasis

Denmark
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)

Hypercholesterolaemia

Netherlands, United States, Canada, Russian Federation, South Africa
Sanofi
Regeneron Pharmaceuticals

Completed

Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)

Hypercholesterolemia

Sweden, Germany, Russian Federation, Denmark, Israel, South Africa, Spain, Hungary, United States, Colombia, Czech Republic, Argentina, Belgium, Bulgaria, Canada, Chile, Finland, France, Italy, Mexico, Netherlands, Norway, Poland, Por... and more
Elysium Health
University of Exeter

Withdrawn

Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance

Healthy

United Kingdom
Aswan University Hospital

Completed

Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

IUCD Complication

Egypt
Elysium Health
KGK Science Inc.

Completed

A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects. (15BSHE)

Safety: Healthy Subjects

Canada
Sanofi

Terminated

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia

Hypercholesterolemia

United States, France, Canada, Poland, Russian Federation, Germany, Netherlands, Spain, Sweden, Belgium, Czech Republic, Denmark, Hungary, Israel, Norway, Australia
Rottapharm

Completed

Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome (ARMP-11)

Metabolic Syndrome | Left Ventricular Hypertrophy | Insulin-resistance

Italy
Harvard School of Public Health (HSPH)
Muhimbili University of Health and Allied Sciences

Completed

Nutrition, Immunology and Epidemiology of Tuberculosis

Tuberculosis

United States
Hospices Civils de Lyon

Completed

Citrulline Efficacy to Improve Carbohydrate Metabolism Abnormalities in the Patient Treated With High Doses of Statin (STATIMPROVE)

Atorvastatin

France
GlaxoSmithKline

Completed

Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy

Atherosclerosis
Zhejiang University
Sir Run Run Shaw Hospital

Unknown

Study Evaluating the Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

China
NantBioScience, Inc.

Active, not recruiting

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Melanoma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Liver Cancer

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

Hypercholesterolemia

Korea, Republic of, Taiwan
The University of Hong Kong
Queen Mary Hospital, Hong Kong; Kowloon Hospital, Hong Kong; Castle Peak Hospital and other collaborators

Completed

Berberine as Adjuvant Treatment for Schizophrenia Patients (BER)

Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Metabolic Syndrome x

Hong Kong
The Affiliated Hospital of Qingdao University

Completed

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Healthy Subjects

China
Azienda di Servizi alla Persona di Pavia

Completed

Polyglucosamine L112 in Overweight and Obese Subjects

Obesity

Italy
Merck Sharp & Dohme LLC

Terminated

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Dyslipidemia
Assaf-Harofeh Medical Center

Completed

Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins

Inflammation | Blood Pressure | Endothelial Function | Platelet Function
Hospital San Carlos, Madrid
Universidad Complutense de Madrid

Not yet recruiting

Oral Bedtime Melatonin in Critically Ill Patients (Mel-ICU)

Septic Shock | Cardiac Arrest | Stroke Hemorrhagic | Strokes Thrombotic
Duke University

Completed

Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling

Male Stress Urinary Incontinence

United States
NYU Langone Health

Completed

Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates

Respiratory Aspiration | Deglutition Disorders | Respiratory Distress Syndrome In Premature Infants | Newborn, Premature
Kyowa Hakko Bio Co., Ltd.
University of Cincinnati

Completed

Citicoline Effects on Cortical Membrane Structure and Function

Healthy

United States
Sandoz

Completed

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions

Healthy

3

Subscribe